NFE2L2 and anti-neutrophil cytoplasmic antibody-associated vasculitis: In antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), pharmacological activation of Nrf2 has been reported to protect endothelial cells and ameliorate glomerulonephritis by inhibiting ROS-induced NETs formation in an AAV mice model [40].